FDA OKs emergency use of AstraZeneca, J&J jabs to be donated by Japan, US | Inquirer News
Close  

FDA OKs emergency use of AstraZeneca, J&J jabs to be donated by Japan, US

By: - Reporter / @KAguilarINQ
/ 12:43 AM July 07, 2021

MANILA, Philippines — The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) to the Department of Health to accept the AstraZeneca and Johnson & Johnson COVID-19 vaccines to be donated by Japan and the United States, respectively.

ADVERTISEMENT

“Regarding AstraZeneca, this is the second most widely used vaccine that we have now in our country. We recently issued an EUA to the Department of Health for them to be able to accept donations from Japan,” FDA Director-General Eric Domingo said, speaking party in Filipino, in a taped briefing with President Rodrigo Duterte that aired Wednesday.

“Last week, we also issued an EUA to the Department of Health for possible donations coming from the USA of Janssen [from] Johnson & Johnson,” he added.

FEATURED STORIES

Japan aims to deliver the one million doses of AstraZeneca COVID-19 vaccine to the Philippines on July 8.

The Philippines also expects to receive up to one million doses of COVID-19 vaccines from the United States this month.

Secretary Carlito Galvez Jr., the country’s vaccine manager, previously said the US donation would likely be from Johnson & Johnson, a single-dose COVID-19 vaccine.

[atm]
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: AstraZeneca, Carlito Galvez Jr., emergency use authorization, Eric Domingo, EUA, FDA, Food and Drug Administration, Johnson & Johnson
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2021 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.